• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟对妊娠早期孕妇血清妊娠相关血浆蛋白-A和游离β人绒毛膜促性腺激素水平的影响。

The influence of smoking on maternal serum PAPP-A and free beta hCG levels in the first trimester of pregnancy.

作者信息

Spencer K

机构信息

Endocrine Unit, Clinical Biochemistry Department, Harold Wood Hospital, Gubbins Lane, Romford, Essex, RM3 0BE, U.K.

出版信息

Prenat Diagn. 1999 Nov;19(11):1065-6. doi: 10.1002/(sici)1097-0223(199911)19:11<1065::aid-pd695>3.0.co;2-r.

DOI:10.1002/(sici)1097-0223(199911)19:11<1065::aid-pd695>3.0.co;2-r
PMID:10589062
Abstract

In an analysis of 3111 singleton pregnancies routinely screened in the first trimester with nuchal translucency, free beta hCG and pregnancy associated plasma protein A (PAPP-A) smoking has been found to occur in 20.8 per cent of pregnant women. When the individual marker levels were assessed in smokers and non-smokers, levels of PAPP-A were reduced in smokers by some 15 per cent. Despite free beta hCG levels being reduced by 10-14 per cent in the second trimester of smoking women, in the first trimester period this is not evident. Simulation studies would suggest that in smokers the detection of trisomy 21 using free beta hCG, PAPP-A and maternal age will be reduced by some 5 to 6 per cent compared with that of the general population.

摘要

在一项对3111例单胎妊娠的分析中,这些妊娠在孕早期常规接受了颈部透明带、游离β-人绒毛膜促性腺激素(β-hCG)和妊娠相关血浆蛋白A(PAPP-A)筛查,结果发现20.8%的孕妇吸烟。当对吸烟者和非吸烟者的个体标志物水平进行评估时,吸烟者的PAPP-A水平降低了约15%。尽管吸烟女性在孕中期游离β-hCG水平降低了10%至14%,但在孕早期这一情况并不明显。模拟研究表明,与普通人群相比,吸烟者使用游离β-hCG、PAPP-A和孕妇年龄检测21三体综合征的检出率将降低约5%至6%。

相似文献

1
The influence of smoking on maternal serum PAPP-A and free beta hCG levels in the first trimester of pregnancy.吸烟对妊娠早期孕妇血清妊娠相关血浆蛋白-A和游离β人绒毛膜促性腺激素水平的影响。
Prenat Diagn. 1999 Nov;19(11):1065-6. doi: 10.1002/(sici)1097-0223(199911)19:11<1065::aid-pd695>3.0.co;2-r.
2
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.一项在孕10至14周时利用胎儿颈部透明带、母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行21三体综合征筛查的项目。
Ultrasound Obstet Gynecol. 1999 Apr;13(4):231-7. doi: 10.1046/j.1469-0705.1999.13040231.x.
3
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.在孕早期使用母体血清生化指标和胎儿颈部透明带厚度筛查染色体异常时校正吸烟状态的影响。
Prenat Diagn. 2004 Mar;24(3):169-73. doi: 10.1002/pd.819.
4
[Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].[妊娠11至14周单胎妊娠中妊娠相关血浆蛋白A(PAPP-A)和人绒毛膜促性腺激素游离β亚基(β-hCG)水平评估及胎儿颈项透明层(NT)的超声评估——波兰多中心研究]
Ginekol Pol. 2007 May;78(5):384-7.
5
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.孕11⁺⁰至13⁺⁶周时,通过胎儿三尖瓣反流、颈部透明带以及母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白-A筛查21三体综合征。
Ultrasound Obstet Gynecol. 2006 Feb;27(2):151-5. doi: 10.1002/uog.2699.
6
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.通过游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行孕早期21三体综合征筛查:孕妇及妊娠特征的影响
Ultrasound Obstet Gynecol. 2008 May;31(5):493-502. doi: 10.1002/uog.5332.
7
Comparison of serum markers in first-trimester down syndrome screening.孕早期唐氏综合征筛查中血清标志物的比较。
Obstet Gynecol. 2006 Nov;108(5):1192-9. doi: 10.1097/01.AOG.0000241095.19638.f2.
8
Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.孕早期唐氏综合征筛查联合测量胎儿颈部透明带厚度、母体血清游离β-人绒毛膜促性腺激素及妊娠相关血浆蛋白A。
J Formos Med Assoc. 2001 May;100(5):319-25.
9
First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.早孕期 7~14 孕周唐氏综合征筛查(二联筛查)。
Ultrasound Obstet Gynecol. 2010 Oct;36(4):404-11. doi: 10.1002/uog.7755.
10
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.孕11至13⁺⁶周时母体血清生化指标与染色体异常胎儿超声检查中胎儿鼻骨存在与否的关系:超声与生化联合筛查的最新分析
Prenat Diagn. 2005 Nov;25(11):977-83. doi: 10.1002/pd.1211.

引用本文的文献

1
The Relationship Between Thrombophilia and Modifications in First-Trimester Prenatal Screening Markers.易栓症与孕早期产前筛查标志物改变之间的关系
Medicina (Kaunas). 2025 Feb 12;61(2):318. doi: 10.3390/medicina61020318.
2
Exploring free pregnancy associated plasma protein a (fPAPP-A) as a biomarker in early pregnancy.探索游离妊娠相关血浆蛋白A(fPAPP-A)作为早期妊娠生物标志物的作用。
Pract Lab Med. 2024 Sep 16;42:e00428. doi: 10.1016/j.plabm.2024.e00428. eCollection 2024 Nov.
3
Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling.
病例报告:两例无创产前检测(NIPT)与羊水穿刺结果明显不一致,导致21三体胎儿-胎盘嵌合体。诊断、调查及咨询中的问题。
Front Genet. 2022 Oct 25;13:982508. doi: 10.3389/fgene.2022.982508. eCollection 2022.
4
First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.用于唐氏综合征筛查的孕早期和孕中期血清检测,以及有无孕早期超声检查的情况。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012599. doi: 10.1002/14651858.CD012599.
5
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.孕早期单独进行超声检查或与孕早期血清检查联合用于唐氏综合征筛查。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600.
6
Urine tests for Down's syndrome screening.唐氏综合征筛查的尿液检测。
Cochrane Database Syst Rev. 2015 Dec 10;2015(12):CD011984. doi: 10.1002/14651858.CD011984.
7
First trimester serum tests for Down's syndrome screening.孕早期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975.
8
Second trimester serum tests for Down's Syndrome screening.孕中期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925.